Research Institute News
![](https://research.cancercare.mb.ca/wp-content/uploads/2023/10/CCMB_Harvey_Chochinov-1.jpg)
May 16, 2024
New book from Institute researcher, Dignity in Care: The Human Side of Medicine helps shape the future of patient care
Senior Scientist at CancerCare Manitoba Research Institute, Dr. Harvey Max Chochinov has published a new book, Dignity in Care: The Human Side of Medicine, providing insight into how the disposition and attitude of healthcare providers indelibly shape patient experience.
![](https://research.cancercare.mb.ca/wp-content/uploads/2023/09/CCMB_Investigator_Initiated.jpg)
New trial looks at reducing bleeding risk in cancer patients while also developing novel research methods
A new Investigator-Initiated Clinical Trial (IICT) led by Primary Investigator, Dr. Brett Houston, called the MYELO-CAN TXA trial, aims to see whether Tranexamic Acid (TXA) can help prevent bleeding in patients with certain blood cancers such as acute leukemia and myelodysplastic syndrome.
![](https://research.cancercare.mb.ca/wp-content/uploads/2023/11/cells-1.jpg)
Advanced magnetic resonance simulator to bring new options for research and treatment
The Institute has acquired a state-of-the-art magnetic resonance simulator (MR-SIM) to be installed in 2024, made possible by generous community donations. The research applications of this technology will include new patient treatment techniques and workflows.
![](https://research.cancercare.mb.ca/wp-content/uploads/2023/11/CCMB_Paul_Albrechtsen.jpg)
$17 million lab renovation enables research creativity and innovation
A major donation from the Paul Albrechtsen Foundation facilitates the transformation of 20-year-old research laboratories into state-of-the-art facilities housing cutting-edge technology and leading scientists pursuing the next cancer breakthroughs.